Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Doxazosin increases low density lipoprotein receptor activity.

T P Leren

    Acta Pharmacologica Et Toxicologica
    |March 1, 1985
    PubMed
    Summary

    The alpha 1 adrenoreceptor antagonist doxazosin significantly boosted low density lipoprotein (LDL) receptor activity in skin cells. This finding may have important clinical implications for managing cholesterol levels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2017
    Same author

    Genetics of hypertrophic cardiomyopathy in Norway.

    Clinical genetics·2013
    Same author

    Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases.

    International journal of legal medicine·2012
    Same author

    Molecular autopsy in young sudden cardiac death victims with suspected cardiomyopathy.

    Forensic science international·2011
    Same author

    The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis.

    Journal of internal medicine·2009
    Same author

    Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers.

    Scandinavian journal of clinical and laboratory investigation·2008

    Area of Science:

    • Pharmacology
    • Molecular Biology
    • Cardiovascular Research

    Background:

    • Low density lipoprotein (LDL) receptors are crucial for cholesterol homeostasis.
    • Alpha 1 adrenoreceptor antagonists, like doxazosin, are used to treat conditions such as hypertension and benign prostatic hyperplasia.
    • The interaction between adrenergic signaling and lipid metabolism is not fully understood.

    Purpose of the Study:

    • To investigate the effect of doxazosin on LDL receptor activity in vitro.
    • To explore potential mechanisms linking alpha 1 adrenoreceptor antagonism to cholesterol regulation.

    Main Methods:

    • Cultured human skin fibroblasts were utilized as the experimental model.
    • Cells were treated with doxazosin at a specific concentration (10(-5) M).
    • LDL receptor activity was measured using established biochemical assays.

    Main Results:

    • Doxazosin treatment led to a statistically significant increase in LDL receptor activity.
    • The observed effect suggests a direct impact of doxazosin on the cellular cholesterol uptake pathway.

    Conclusions:

    • Doxazosin enhances LDL receptor activity in cultured skin fibroblasts.
    • This finding opens new avenues for exploring doxazosin's potential role in lipid management.
    • Further research is warranted to elucidate the clinical relevance and therapeutic potential in cardiovascular health.

    Related Experiment Videos